Featured Research

from universities, journals, and other organizations

Some hospitalized children exposed to many medications and therapeutic agents, study finds

Date:
September 6, 2011
Source:
JAMA and Archives Journals
Summary:
Some hospitalized pediatric patients, particularly those with rare conditions, may be exposed to many drugs and therapeutic agents, according to a new report.

Some hospitalized pediatric patients, particularly those with rare conditions, may be exposed to many drugs and therapeutic agents, according to a report published Online First by Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals.

According to background information in the article, many drugs used for children in the hospital setting do not have well-established pediatric efficacy and safety profiles. Some medication use in this population is for off-label indications. Further, medication errors do occur, the authors note. In the last decade, lawmakers have endorsed measures to encourage the study of pediatric treatments, improve labeling of medications intended for children and reduce medication errors in hospitalized children. "To advance this agenda, we need to refine our knowledge of the overall patterns of pediatric inpatient drug and therapeutic agent use, including what drugs and therapeutic agents are used most commonly, the number of different drugs and therapeutic agents that hospitalized children receive, and potential differences in drug and therapeutic agent exposures across different types of hospitals," write the authors. "This knowledge, especially if based on population-level data, would enhance efforts to prioritize and design research studies regarding the effectiveness and safety of pediatric inpatient medications."

Chris Feudtner, M.D., Ph.D., M.P.H., from Children's Hospital of Philadelphia, and colleagues conducted a retrospective study of 2006 data from the Pediatric Health Information System, which includes children's hospitals in U.S. major metropolitan areas, and the Perspective Data Warehouse, which includes U.S. academic medical centers, community-based hospitals and large systems of multiple hospitals. The researchers reassigned the records into two categories: 365,868 pediatric patients younger than 18 years who experienced 491,451 hospitalizations in 52 children's hospitals; and 221,559 pediatric patients who experienced 260,740 hospitalizations in 411 general hospitals. These data represent roughly 19.9 percent of all U.S. pediatric inpatient hospitalizations. The researchers examined demographic and clinical characteristics as well as patients' exposures to medications and therapeutic agents.

The most common exposures varied by patient age and by hospital type, with acetaminophen, albuterol and antibiotics the most prevalent medication exposures. There was an association between length of stay and the number of drug and therapeutic agent exposures. On day one of hospitalization, in children's hospitals, patients younger than one year at the 90th percentile of daily medication exposure received 11 drugs and those one year or older received 13 drugs. In general hospitals, those younger than one year received 8 drugs and those one year or older received 12 drugs. By day seven of hospitalization, in children's hospitals, patients younger than one year in the 90th percentile of cumulative exposure to distinct medications had received 29 drugs; patients one year or older had received 35 drugs. In general hospitals, patients younger than one year had received 22 drugs; patients one year or older had received 28 drugs. Pediatric patients with rare conditions appeared more likely than other pediatric patients to receive more exposures to drugs and other therapeutic agents.

"The findings and the data of this study offer at least three important means to improve pediatric inpatient medication efficacy, effectiveness, and safety," write the authors. First, the rankings of drugs and therapeutic agents in terms of most frequent exposure for hospitalized children can suggest priorities for further research. Next, the level of polypharmacy (use of multiple drugs or therapeutic agents) that researchers found could raise concerns for patient safety, because polypharmacy in adults has been associated with adverse drug events. Lastly, the authors note, the information in these databases could provide the opportunity for comparative effectiveness and safety studies to be conducted. (Arch Pediatr Adoles Med. Published online September 5, 2011.

Editorial: Pediatric Polypharmacy

In an accompanying editorial, Nancy E. Morden, M.D., M.P.H., and David Goodman, M.D., M.S., both from the Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Lebanon, N.H., examine the implications of the article by Feudtner et al. "Polypharmacy is the norm for hospitalized infants and children," they write. "Should we be concerned?"

Morden and Goodman note that they "share the authors' unease with the level of polypharmacy in pediatric inpatient settings." However, they add, additional data could provide a clearer picture of the effect that polypharmacy actually has on children. Noting that other research suggests undertreatment of pain and possible overuse of antimicrobial and respiratory agents in this population, Morden and Goodman ask, "Are pediatric patients receiving too much or too little?"

According to Morden and Goodman, the article by Feudtner and colleagues suggests that medication exposure varies across hospitals for asthma, appendectomy and seizure. They recommend these variations as an area for further study, as well as other related topics. For instance, linking exposure patterns to outcomes data could reveal ways to better use medications, and research might also examine outpatient pediatric polypharmacy or how long-term polypharmacy affects children.

"Clinicians, policy makers, researchers, and patient advocates should collaborate on efforts aimed at promoting the development of evidence to inform pediatric pharmacotherapy," Morden and Goodman conclude. "Moving toward an understanding of the balance of risks and benefits will require better data, a sustained research program, and a commitment to translating new knowledge into better practice."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal References:

  1. C. Feudtner, D. Dai, K. R. Hexem, X. Luan, T. A. Metjian. Prevalence of Polypharmacy Exposure Among Hospitalized Children in the United States. Archives of Pediatrics and Adolescent Medicine, 2011; DOI: 10.1001/archpediatrics.2011.161
  2. N. E. Morden, D. Goodman. Pediatric Polypharmacy: Time to Lock the Medicine Cabinet? Archives of Pediatrics and Adolescent Medicine, 2011; DOI: 10.1001/archpediatrics.2011.162

Cite This Page:

JAMA and Archives Journals. "Some hospitalized children exposed to many medications and therapeutic agents, study finds." ScienceDaily. ScienceDaily, 6 September 2011. <www.sciencedaily.com/releases/2011/09/110906182726.htm>.
JAMA and Archives Journals. (2011, September 6). Some hospitalized children exposed to many medications and therapeutic agents, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/09/110906182726.htm
JAMA and Archives Journals. "Some hospitalized children exposed to many medications and therapeutic agents, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/09/110906182726.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins